These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9274705)

  • 1. Insulin action and hepatic glucose cycling in Cushing's syndrome.
    Heaney AP; Harper R; Ennis C; Rooney DP; Sheridan B; Atkinson AB; Bell PM
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):735-43. PubMed ID: 9274705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin action and hepatic glucose cycling in essential hypertension.
    Rooney DP; Neely RD; Ennis CN; Bell NP; Sheridan B; Atkinson AB; Trimble ER; Bell PM
    Metabolism; 1992 Mar; 41(3):317-24. PubMed ID: 1542271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cortisol on glucose/glucose-6-phosphate cycle activity and insulin action.
    Rooney DP; Neely RD; Cullen C; Ennis CN; Sheridan B; Atkinson AB; Trimble ER; Bell PM
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1180-3. PubMed ID: 8077310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis.
    Page R; Boolell M; Kalfas A; Sawyer S; Pestell R; Ward G; Alford F
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):509-17. PubMed ID: 1769133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid metabolism and insulin resistance in cirrhosis.
    Kaye GL; Kruszynska YT; Harry DS; Heslop K; Johnston DG; McIntyre N
    J Hepatol; 1994 Jun; 20(6):782-91. PubMed ID: 7930479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus.
    Rooney DP; Neely RD; Beatty O; Bell NP; Sheridan B; Atkinson AB; Trimble ER; Bell PM
    Diabetologia; 1993 Feb; 36(2):106-12. PubMed ID: 8458523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal and metabolic rhythms in Cushing's syndrome.
    Johnston DG; Alberti KG; Nattrass M; Barnes AJ; Bloom SR; Joplin GF
    Metabolism; 1980 Oct; 29(11):1046-52. PubMed ID: 7001175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in Cushing's syndrome.
    Nosadini R; Del Prato S; Tiengo A; Valerio A; Muggeo M; Opocher G; Mantero F; Duner E; Marescotti C; Mollo F; Belloni F
    J Clin Endocrinol Metab; 1983 Sep; 57(3):529-36. PubMed ID: 6348064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in Cushing's syndrome.
    Karnieli E; Cohen P; Barzilai N; Ish-Shalom Z; Armoni M; Rafaelov R; Barzilai D
    Horm Metab Res; 1985 Oct; 17(10):518-21. PubMed ID: 3905556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic glucose production during intraperitoneal and intravenous closed-loop insulin regulation of blood glucose in type 1 (insulin-dependent) diabetic patients.
    Robert JJ; Chauvet D; Darmaun D; Leblanc H
    Diabetologia; 1993 Nov; 36(11):1185-90. PubMed ID: 8270134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.
    Bugianesi E; Gastaldelli A; Vanni E; Gambino R; Cassader M; Baldi S; Ponti V; Pagano G; Ferrannini E; Rizzetto M
    Diabetologia; 2005 Apr; 48(4):634-42. PubMed ID: 15747110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose metabolism in patients with Cushing's syndrome.
    Bowes SB; Benn JJ; Scobie IN; Umpleby AM; Lowy C; Sönksen PH
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):311-6. PubMed ID: 1879061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical investigation on the mechanism of glucose intolerance in Cushing's syndrome].
    Takeda N; Yasuda K; Horiya T; Yamada H; Imai T; Kitada M; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):631-48. PubMed ID: 3525245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin regulation of glucose and lipid metabolism in massive obesity.
    Del Prato S; Enzi G; Vigili de Kreutzenberg S; Lisato G; Riccio A; Maifreni L; Iori E; Zurlo F; Sergi G; Tiengo A
    Diabetologia; 1990 Apr; 33(4):228-36. PubMed ID: 2189770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK; van de Werve G; Giacca A
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine metabolism in patients with Cushing's syndrome before and after successful treatment.
    Bowes SB; Benn JJ; Scobie IN; Umpleby AM; Lowy C; Sönksen PH
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):591-8. PubMed ID: 8252750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man.
    Johnson AB; Argyraki M; Thow JC; Cooper BG; Fulcher G; Taylor R
    Clin Sci (Lond); 1992 Feb; 82(2):219-26. PubMed ID: 1311661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes.
    Nankervis A; Proietto J; Aitken P; Harewood M; Alford F
    Diabetologia; 1982 Oct; 23(4):320-5. PubMed ID: 6754516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.